
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $609M | $942.9M | $1.5B | $1.6B | $1.6B | |
Revenue Growth (YoY) | -16.28% | 54.83% | 55.83% | 6.19% | 4.87% | |
Cost of Revenues | $374.9M | $585.8M | $864.5M | $889.8M | $910.2M | |
Gross Profit | $234.1M | $357.1M | $604.8M | $670.5M | $726.1M | |
Gross Profit Margin | 38.44% | 37.87% | 41.16% | 42.97% | 44.38% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $102.8M | $167.6M | $229.7M | $253.5M | $279.3M | |
Other Inc / (Exp) | -$6M | -$34.1M | -$18.8M | -$5.9M | -$2.1M | |
Operating Expenses | $113.5M | $202.8M | $299.6M | $324.1M | $352.3M | |
Operating Income | $120.6M | $154.3M | $305.2M | $346.4M | $373.8M | |
Net Interest Expenses | $1.4M | $41.5M | $76.7M | $78.7M | $59.8M | |
EBT. Incl. Unusual Items | $113.2M | $78.7M | $209.7M | $261.8M | $311.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $23.1M | $24M | $43M | $51.9M | $65.7M | |
Net Income to Company | $90.1M | $54.7M | $166.7M | $209.9M | $246.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $90.1M | $54.7M | $166.7M | $209.9M | $246.2M | |
Basic EPS (Cont. Ops) | $3.63 | $1.58 | $5.00 | $6.47 | $7.76 | |
Diluted EPS (Cont. Ops) | $3.58 | $1.56 | $4.94 | $6.41 | $7.70 | |
Weighted Average Basic Share | $24.9M | $26.9M | $28.8M | $28.9M | $30.1M | |
Weighted Average Diluted Share | $25.1M | $27.3M | $29.1M | $29.2M | $30.4M | |
EBITDA | $146.8M | $185.7M | $401.8M | $459.8M | $491.7M | |
EBIT | $114.1M | $120.2M | $286.4M | $340.5M | $371.7M | |
Revenue (Reported) | $609M | $942.9M | $1.5B | $1.6B | $1.6B | |
Operating Income (Reported) | $120.6M | $154.3M | $305.2M | $346.4M | $373.8M | |
Operating Income (Adjusted) | $114.1M | $120.2M | $286.4M | $340.5M | $371.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $160.3M | $358.8M | $394.4M | $413.7M | $437.7M | |
Revenue Growth (YoY) | -13.74% | 123.84% | 9.91% | 4.89% | 5.8% | |
Cost of Revenues | $97.8M | $221.3M | $227.9M | $235.4M | $244.3M | |
Gross Profit | $62.5M | $137.5M | $166.5M | $178.3M | $193.4M | |
Gross Profit Margin | 38.96% | 38.32% | 42.22% | 43.1% | 44.19% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $24.2M | $54.5M | $59.6M | $64.4M | $72.1M | |
Other Inc / (Exp) | $5.5M | $11.2M | -$7.4M | -$4.8M | -$3.3M | |
Operating Expenses | $34.9M | $89.7M | $77.1M | $80.6M | $89.4M | |
Operating Income | $27.6M | $47.9M | $89.4M | $97.7M | $104M | |
Net Interest Expenses | $305K | $13.6M | $21.7M | $18.8M | $12.8M | |
EBT. Incl. Unusual Items | $32.8M | $45.5M | $60.3M | $74.1M | $87.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.4M | $14.1M | $11.1M | $12.5M | $15.2M | |
Net Income to Company | $25.4M | $31.5M | $49.2M | $61.6M | $72.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $25.4M | $31.5M | $49.2M | $61.6M | $72.7M | |
Basic EPS (Cont. Ops) | $1.00 | $0.90 | $1.51 | $1.93 | $2.32 | |
Diluted EPS (Cont. Ops) | $0.99 | $0.89 | $1.49 | $1.91 | $2.30 | |
Weighted Average Basic Share | $25M | $28.6M | $28.8M | $29M | $31.3M | |
Weighted Average Diluted Share | $25.6M | $29M | $29.1M | $29.3M | $31.6M | |
EBITDA | $40.5M | $87.2M | $111.6M | $122.6M | $130.8M | |
EBIT | $32.6M | $59.1M | $82M | $92.9M | $100.7M | |
Revenue (Reported) | $160.3M | $358.8M | $394.4M | $413.7M | $437.7M | |
Operating Income (Reported) | $27.6M | $47.9M | $89.4M | $97.7M | $104M | |
Operating Income (Adjusted) | $32.6M | $59.1M | $82M | $92.9M | $100.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $609M | $942.9M | $1.5B | $1.6B | $1.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $374.9M | $585.8M | $864.5M | $889.8M | $910.2M | |
Gross Profit | $234.1M | $357.1M | $604.8M | $670.5M | $726.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $102.8M | $167.6M | $229.7M | $253.5M | $279.3M | |
Other Inc / (Exp) | -$6M | -$34.1M | -$53.6M | -$41.5M | -$38.6M | |
Operating Expenses | $113.5M | $202.8M | $264.8M | $288.5M | $315.8M | |
Operating Income | $120.6M | $154.3M | $340M | $382M | $410.3M | |
Net Interest Expenses | $1.4M | $41.5M | $76.7M | $78.7M | $59.8M | |
EBT. Incl. Unusual Items | $113.2M | $78.7M | $209.7M | $261.8M | $311.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $23.1M | $24M | $43M | $51.9M | $65.7M | |
Net Income to Company | $90.1M | $54.7M | $166.7M | $209.9M | $246.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $90.1M | $54.7M | $166.7M | $209.9M | $246.2M | |
Basic EPS (Cont. Ops) | $3.61 | $1.61 | $5.00 | $6.46 | $7.74 | |
Diluted EPS (Cont. Ops) | $3.58 | $1.59 | $4.94 | $6.40 | $7.67 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $146.8M | $185.7M | $401.8M | $459.8M | $491.7M | |
EBIT | $114.1M | $120.2M | $286.4M | $340.5M | $371.7M | |
Revenue (Reported) | $609M | $942.9M | $1.5B | $1.6B | $1.6B | |
Operating Income (Reported) | $120.6M | $154.3M | $340M | $382M | $410.3M | |
Operating Income (Adjusted) | $114.1M | $120.2M | $286.4M | $340.5M | $371.7M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $942.9M | $1.5B | $1.6B | $1.6B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $585.8M | $864.5M | $889.8M | $910.2M | -- | |
Gross Profit | $357.1M | $604.8M | $670.5M | $726.1M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $167.6M | $229.7M | $253.5M | $279.3M | -- | |
Other Inc / (Exp) | -$34.1M | -$53.6M | -$41.5M | -$38.6M | -- | |
Operating Expenses | $202.8M | $264.8M | $288.5M | $315.8M | -- | |
Operating Income | $154.3M | $340M | $382M | $410.3M | -- | |
Net Interest Expenses | $41.5M | $76.7M | $78.7M | $59.8M | -- | |
EBT. Incl. Unusual Items | $78.7M | $209.7M | $261.8M | $311.9M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24M | $43M | $51.9M | $65.7M | -- | |
Net Income to Company | $54.7M | $166.7M | $209.9M | $246.2M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $54.7M | $166.7M | $209.9M | $246.2M | -- | |
Basic EPS (Cont. Ops) | $1.61 | $5.00 | $6.46 | $7.74 | -- | |
Diluted EPS (Cont. Ops) | $1.59 | $4.94 | $6.40 | $7.67 | -- | |
Weighted Average Basic Share | $107.8M | $115.1M | $115.7M | $120.5M | -- | |
Weighted Average Diluted Share | $108.5M | $116.3M | $116.8M | $121.4M | -- | |
EBITDA | $185.7M | $401.8M | $459.8M | $491.7M | -- | |
EBIT | $120.2M | $286.4M | $340.5M | $371.7M | -- | |
Revenue (Reported) | $942.9M | $1.5B | $1.6B | $1.6B | -- | |
Operating Income (Reported) | $154.3M | $340M | $382M | $410.3M | -- | |
Operating Income (Adjusted) | $120.2M | $286.4M | $340.5M | $371.7M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $151.1M | $182.9M | $65.4M | $63.5M | $36.8M | |
Short Term Investments | $90.2M | -- | -- | -- | -- | |
Accounts Receivable, Net | $110.5M | $247.5M | $239.6M | $255.2M | $307.6M | |
Inventory | $364.1M | $516.1M | $587.2M | $622.8M | $654.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $12.2M | $15.7M | $21.1M | $24M | $28.4M | |
Total Current Assets | $728.2M | $962.2M | $913.3M | $965.5M | $1B | |
Property Plant And Equipment | $243.9M | $431.2M | $416.7M | $402.4M | $417.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $277.5M | $1.9B | $1.9B | $1.9B | $1.9B | |
Other Intangibles | $154.4M | $1.5B | $1.5B | $1.4B | $1.3B | |
Other Long-Term Assets | $30.2M | $38.4M | $37.7M | $43.9M | $43M | |
Total Assets | $1.4B | $4.8B | $4.7B | $4.7B | $4.7B | |
Accounts Payable | $36.3M | $158.6M | $146.8M | $116.2M | $138.4M | |
Accrued Expenses | $3.2M | $59.6M | $61.3M | $58.9M | $63.7M | |
Current Portion Of Long-Term Debt | $2.6M | $1.5M | $1.5M | $3.8M | $1.7M | |
Current Portion Of Capital Lease Obligations | $5.7M | $12M | $12.8M | $12.7M | $15.1M | |
Other Current Liabilities | $5.7M | $9.8M | $8.4M | $16.2M | $6.9M | |
Total Current Liabilities | $88.2M | $313.5M | $309.3M | $294.3M | $315.3M | |
Long-Term Debt | $13.5M | $1.7B | $1.4B | $1.2B | $918.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $202.2M | $2.5B | $2.2B | $1.9B | $1.7B | |
Common Stock | $261K | $300K | $300K | $300K | $300K | |
Other Common Equity Adj | -$10.4M | -$5.8M | -$4.1M | $700K | -$1.4M | |
Common Equity | $1.2B | $2.4B | $2.5B | $2.8B | $3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.2B | $2.4B | $2.5B | $2.8B | $3B | |
Total Liabilities and Equity | $1.4B | $4.8B | $4.7B | $4.7B | $4.7B | |
Cash and Short Terms | $241.3M | $182.9M | $65.4M | $63.5M | $36.8M | |
Total Debt | $16.1M | $1.7B | $1.4B | $1.2B | $920.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $151.1M | $182.9M | $65.4M | $63.5M | $36.8M | |
Short Term Investments | $90.2M | -- | -- | -- | -- | |
Accounts Receivable, Net | $110.5M | $247.5M | $239.6M | $255.2M | $307.6M | |
Inventory | $364.1M | $516.1M | $587.2M | $622.8M | $654.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $12.2M | $15.7M | $21.1M | $24M | $28.4M | |
Total Current Assets | $728.2M | $962.2M | $913.3M | $965.5M | $1B | |
Property Plant And Equipment | $243.9M | $431.2M | $416.7M | $402.4M | $417.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $277.5M | $1.9B | $1.9B | $1.9B | $1.9B | |
Other Intangibles | $154.4M | $1.5B | $1.5B | $1.4B | $1.3B | |
Other Long-Term Assets | $30.2M | $38.4M | $37.7M | $43.9M | $43M | |
Total Assets | $1.4B | $4.8B | $4.7B | $4.7B | $4.7B | |
Accounts Payable | $36.3M | $158.6M | $146.8M | $116.2M | $138.4M | |
Accrued Expenses | $3.2M | $59.6M | $61.3M | $58.9M | $63.7M | |
Current Portion Of Long-Term Debt | $2.6M | $1.5M | $1.5M | $3.8M | $1.7M | |
Current Portion Of Capital Lease Obligations | $5.7M | $12M | $12.8M | $12.7M | $15.1M | |
Other Current Liabilities | $5.7M | $9.8M | $8.4M | $16.2M | $6.9M | |
Total Current Liabilities | $88.2M | $313.5M | $309.3M | $294.3M | $315.3M | |
Long-Term Debt | $13.5M | $1.7B | $1.4B | $1.2B | $918.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $202.2M | $2.5B | $2.2B | $1.9B | $1.7B | |
Common Stock | $261K | $300K | $300K | $300K | $300K | |
Other Common Equity Adj | -$10.4M | -$5.8M | -$4.1M | $700K | -$1.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -$19K | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.2B | $2.4B | $2.5B | $2.8B | $3B | |
Total Liabilities and Equity | $1.4B | $4.8B | $4.7B | $4.7B | $4.7B | |
Cash and Short Terms | $241.3M | $182.9M | $65.4M | $63.5M | $36.8M | |
Total Debt | $16.1M | $1.7B | $1.4B | $1.2B | $920.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $90.1M | $54.7M | $166.7M | $209.9M | $246.2M | |
Depreciation & Amoritzation | $32.7M | $65.5M | $115.4M | $119.3M | $120M | |
Stock-Based Compensation | $18.1M | $32.9M | $14M | $17.4M | $28.4M | |
Change in Accounts Receivable | $19M | -$53.5M | $7.8M | -$13.4M | -$53.3M | |
Change in Inventories | $900K | -$16.2M | -$71.7M | -$31.6M | -$32.3M | |
Cash From Operations | $152.4M | $180.3M | $220.6M | $274.7M | $293.6M | |
Capital Expenditures | $11.8M | $29.8M | $42M | $33.2M | $49.8M | |
Cash Acquisitions | $300K | -$2.9B | $27.5M | -$19.3M | -- | |
Cash From Investing | -$101.5M | -$2.8B | -$14M | -$52.2M | -$49.8M | |
Dividends Paid (Ex Special Dividend) | -- | -$7.1M | -$22.9M | -$23M | -$17.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $1.8B | -- | $20.3M | $71.5M | |
Long-Term Debt Repaid | -$7.9M | -$115.1M | -$303.7M | -$230.2M | -$350.1M | |
Repurchase of Common Stock | -$6.8M | -$8.6M | -$7.7M | -$11M | -$9.5M | |
Other Financing Activities | -- | -$19.5M | -$100K | -- | -- | |
Cash From Financing | -$3.4M | $2.7B | -$322.8M | -$223.5M | -$270.4M | |
Beginning Cash (CF) | $103.3M | $151.1M | $182.9M | $65.4M | $63.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $47.5M | $31.3M | -$116.2M | -$1M | -$26.6M | |
Ending Cash (CF) | $151.1M | $182.9M | $65.4M | $63.5M | $36.8M | |
Levered Free Cash Flow | $140.6M | $150.5M | $178.6M | $241.5M | $243.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $24M | $37.4M | $50M | $61.4M | -- | |
Depreciation & Amoritzation | $8.2M | $28.6M | $29.7M | $30M | -- | |
Stock-Based Compensation | $7.2M | $3.8M | $5.4M | $6.5M | -- | |
Change in Accounts Receivable | $4.9M | $11.4M | -$12M | $500K | -- | |
Change in Inventories | -$4.9M | -$28.2M | -$15.6M | -$12.1M | -- | |
Cash From Operations | $53.3M | $59M | $61.7M | $97.4M | -- | |
Capital Expenditures | $3.4M | $7.9M | $6.7M | $9M | -- | |
Cash Acquisitions | -- | $23M | -- | -- | -- | |
Cash From Investing | -$33.3M | $15.2M | -$6.5M | -$9M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -$5.7M | -$5.7M | -$5.7M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$5.9M | -$126.2M | -$52.1M | -$62.2M | -- | |
Repurchase of Common Stock | -$6.3M | -$6M | -$6.8M | -$8M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $4.5M | -$136.4M | -$63.6M | -$74.7M | -- | |
Beginning Cash (CF) | $151.1M | $182.9M | $65.4M | $63.5M | -- | |
Foreign Exchange Rate Adjustment | $167K | -$1.1M | -$300K | -$400K | -- | |
Additions / Reductions | $24.5M | -$62.2M | -$8.4M | $13.7M | -- | |
Ending Cash (CF) | $175.8M | $119.6M | $56.7M | $76.8M | -- | |
Levered Free Cash Flow | $49.9M | $51.1M | $55M | $88.4M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $90.1M | $54.7M | $166.7M | $209.9M | $246.2M | |
Depreciation & Amoritzation | $32.7M | $65.5M | $115.4M | $119.3M | $120M | |
Stock-Based Compensation | $18.1M | $32.9M | $14M | $17.4M | $28.4M | |
Change in Accounts Receivable | $19M | -$53.5M | $7.8M | -$13.4M | -$53.3M | |
Change in Inventories | $900K | -$16.2M | -$71.7M | -$31.6M | -$32.3M | |
Cash From Operations | $152.4M | $180.3M | $220.6M | $274.7M | $293.6M | |
Capital Expenditures | $11.8M | $29.8M | $42M | $33.2M | $49.8M | |
Cash Acquisitions | $300K | -$2.9B | $27.5M | -$19.3M | -- | |
Cash From Investing | -$101.5M | -$2.8B | -$14M | -$52.2M | -$49.8M | |
Dividends Paid (Ex Special Dividend) | -- | -$7.1M | -$22.9M | -$23M | -$17.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$7.9M | -$115.1M | -$303.7M | -$230.2M | -$350.1M | |
Repurchase of Common Stock | -$6.8M | -$8.6M | -$7.7M | -$11M | -$9.5M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$3.4M | $2.7B | -$322.8M | -$223.5M | -$270.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $47.5M | $31.3M | -$116.2M | -$1M | -$26.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $140.6M | $150.5M | $178.6M | $241.5M | $243.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $24M | $37.4M | $50M | $61.4M | -- | |
Depreciation & Amoritzation | $8.2M | $28.6M | $29.7M | $30M | -- | |
Stock-Based Compensation | $7.2M | $3.8M | $5.4M | $6.5M | -- | |
Change in Accounts Receivable | $4.9M | $11.4M | -$12M | $500K | -- | |
Change in Inventories | -$4.9M | -$28.2M | -$15.6M | -$12.1M | -- | |
Cash From Operations | $53.3M | $59M | $61.7M | $97.4M | -- | |
Capital Expenditures | $3.4M | $7.9M | $6.7M | $9M | -- | |
Cash Acquisitions | -- | $23M | -- | -- | -- | |
Cash From Investing | -$33.3M | $15.2M | -$6.5M | -$9M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -$5.7M | -$5.7M | -$5.7M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$5.9M | -$126.2M | -$52.1M | -$62.2M | -- | |
Repurchase of Common Stock | -$6.3M | -$6M | -$6.8M | -$8M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $4.5M | -$136.4M | -$63.6M | -$74.7M | -- | |
Beginning Cash (CF) | $151.1M | $182.9M | $65.4M | $63.5M | -- | |
Foreign Exchange Rate Adjustment | $167K | -$1.1M | -$300K | -$400K | -- | |
Additions / Reductions | $24.5M | -$62.2M | -$8.4M | $13.7M | -- | |
Ending Cash (CF) | $175.8M | $119.6M | $56.7M | $76.8M | -- | |
Levered Free Cash Flow | $49.9M | $51.1M | $55M | $88.4M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.